Payment overview · 2025
General Payments
$21.68
1 reported records · 1 companies
Healthcare provider profile · identity verified
Aaron M Morgan, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · BREWTON, AL · NPI 1932391661
Verified facts
What the public records show
CMS Open Payments records show Aaron M Morgan, M.D. received $21.68 in general payments during 2025 across 1 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $21.68 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.68 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.68 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1886 | 254 |
| Gabapentin | Gabapentin | 886 | 139 |
| Atorvastatin Calcium | Atorvastatin Calcium | 798 | 247 |
| Amlodipine Besylate | Amlodipine Besylate | 552 | 163 |
| Meloxicam | Meloxicam | 408 | 111 |
| Lisinopril | Lisinopril | 406 | 126 |
| Levothyroxine Sodium | Levothyroxine Sodium | 365 | 102 |
| Tizanidine Hcl | Tizanidine Hcl | 342 | 105 |
| Pantoprazole Sodium | Pantoprazole Sodium | 296 | 103 |
| Omeprazole | Omeprazole | 294 | 85 |
| Losartan Potassium | Losartan Potassium | 257 | 75 |
| Potassium Chloride | Potassium Chloride | 249 | 79 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 229 | 75 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 226 | 72 |
| Tramadol Hcl | Tramadol Hcl | 223 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 222 | 66 |
| Furosemide | Furosemide | 216 | 76 |
| Glipizide | Glipizide | 214 | 54 |
| Metformin Hcl | Metformin Hcl | 207 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 201 | 59 |
| Gemfibrozil | Gemfibrozil | 194 | 61 |
| Hydrochlorothiazide | Hydrochlorothiazide | 190 | 60 |
| Montelukast Sodium | Montelukast Sodium | 184 | 60 |
| Escitalopram Oxalate | Escitalopram Oxalate | 178 | 50 |
| Carvedilol | Carvedilol | 171 | 48 |
| Jardiance | Empagliflozin | 157 | 30 |
| Eliquis | Apixaban | 152 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 41 |
| Linzess | Linaclotide | 128 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 127 | 41 |
| Pregabalin | Pregabalin | 126 | 20 |
| Simvastatin | Simvastatin | 125 | 37 |
| Methylprednisolone | Methylprednisolone | 122 | 111 |
| Clopidogrel | Clopidogrel Bisulfate | 121 | 34 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 119 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 118 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 33 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 113 | 35 |
| Azithromycin | Azithromycin | 111 | 102 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 111 | 33 |
| Allopurinol | Allopurinol | 109 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 108 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 102 | 29 |
| Mounjaro | Tirzepatide | 100 | 19 |
| Trazodone Hcl | Trazodone Hcl | 96 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 95 | 24 |
| Spironolactone | Spironolactone | 93 | 26 |
| Ondansetron Odt | Ondansetron | 86 | 40 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 39 |
| Promethazine Hcl | Promethazine Hcl | 82 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 79 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 74 | 26 |
| Methocarbamol | Methocarbamol | 74 | 29 |
| Meclizine Hcl | Meclizine Hcl | 70 | 32 |
| Hydralazine Hcl | Hydralazine Hcl | 68 | 28 |
| Ozempic | Semaglutide | 64 | 11 |
| Prednisone | Prednisone | 60 | 39 |
| Clonidine | Clonidine | 57 | 13 |
| Ezetimibe | Ezetimibe | 56 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 55 | suppressed |
| Bumetanide | Bumetanide | 53 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 53 | 14 |
| Glimepiride | Glimepiride | 53 | 14 |
| Bupropion Xl | Bupropion Hcl | 51 | 14 |
| Sucralfate | Sucralfate | 50 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 45 |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 27 |
| Buspirone Hcl | Buspirone Hcl | 48 | 13 |
| Farxiga | Dapagliflozin Propanediol | 48 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 47 | 14 |
| Atenolol | Atenolol | 42 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | 11 |
| Dilt-Xr | Diltiazem Hcl | 42 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | suppressed |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Entresto | Sacubitril/Valsartan | 39 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 37 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 33 |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 33 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 33 | suppressed |
| Nystatin | Nystatin | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 25 |
| Clonazepam | Clonazepam | 29 | suppressed |
| Famotidine | Famotidine | 29 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 28 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 28 | suppressed |
| Vraylar | Cariprazine Hcl | 28 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Mupirocin | Mupirocin | 27 | 22 |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Ubrelvy | Ubrogepant | 26 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 11 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 23 | suppressed |
| Cephalexin | Cephalexin | 23 | 18 |
| Glipizide Er | Glipizide | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Ibuprofen | Ibuprofen | 22 | 11 |
| Methotrexate | Methotrexate Sodium | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | 14 |
| Ramipril | Ramipril | 21 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 14 |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | 13 |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 13 | 13 |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Vyvanse | Lisdexamfetamine Dimesylate | 13 | suppressed |
| Buprenorphine | Buprenorphine | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Odefsey | Emtricitab/Rilpiviri/Tenof Ala | 11 | suppressed |
| Tobramycin | Tobramycin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.68 · 1 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error